Article15 November 1990

Infection with Human Immunodeficiency Virus Type 1 (HIV-1) among Recipients of Antibody-Positive Blood Donations

    Author, Article, and Disclosure Information


    Objective: To assess the incidence of human immunodeficiency virus type 1 (HIV-1) transmission by antibody (anti-HIV-1)-positive blood components, and to determine the immunologic and clinical course in HIV-1-infected recipients.

    Design and Subjects: We retrospectively tested approximately 200 000 donor blood component specimens stored in late 1984 and 1985 for anti-HIV-1, and we contacted recipients of positive specimens to determine their serologic status. They were compared with both recipients of HIV-1-negative transfusions and healthy (untransfused) controls. Subjects were seen at 3- to 6-month intervals for up to 4 years for clinical and immunologic evaluations.

    Measurements and Main Results: Of 133 recipients, 9 had other possible exposures. Excluding these cases, 111 of 124 (89.5%) were anti-HIV-1-positive (95% CI, 84.1% to 94.5%). The recipient's sex, age, underlying condition, and type of component did not influence infection rates. The cumulative risk for developing the acquired immunodeficiency syndrome (AIDS) within 38 months after transfusion was 13% (CI, 7.5% to 21.6%). At 36 ± 3 months after the index transfusion, seropositive recipients had lower counts of CD2+CDw26+, CD4+, CD4+CD29+, and CD4+CD45RA+ subsets and more CD8+I2+ lymphocytes than did recipients of anti-HIV-1-negative transfusions. The CD4+ and CD2+CDw26+ subsets changed the most rapidly. The absolute CD8+ count remained normal.

    Conclusions: Transfusion of anti-HIV-1-positive blood infected 90% of recipients. The rate of progression to AIDS within the first 38 months after infection was similar to that reported for homosexual men and hemophiliacs. Although most lymphocyte subset counts changed over time, CD8+ counts were constant.


    • 1. . Possible transfusion-associated acquired immune deficiency syndrome (AIDS)—California. MMWR. 1982;31:652-4. MedlineGoogle Scholar
    • 2. Ammann AWara D, and Dritz S. Acquired immunodeficiency in an infant: possible transmission by means of blood products. Lancet. 1983;1:956-8. CrossrefMedlineGoogle Scholar
    • 3. . Human immunodeficiency virus infection in transfusion recipients and their family members. MMWR. 1987;36:137-40. MedlineGoogle Scholar
    • 4. Ward JDeppe D, and Samson S. Risk of human immunodeficiency virus infection from blood donors who later developed the acquired immunodeficiency syndrome. Ann Intern Med. 1987;106: 61-2. LinkGoogle Scholar
    • 5. Ward JBush T, and Perkins H. The natural history of transfusion-associated infection with human immunodeficiency virus: factors influencing the rate of progression to disease. N Engl J Med. 1989;321:947-52. CrossrefMedlineGoogle Scholar
    • 6. Ng AConway MBlanda EKilligrew R, and Eastman C. Tracing HIV-infected blood recipients: large-scale recipient screening vs. look-back testing. JAMA. 1987;258:201-2. CrossrefMedlineGoogle Scholar
    • 7. Kleinman SNiland J, and Azen S. Prevalence of antibodies to human immunodeficiency virus type 1 among blood donors prior to screening: the Transfusion Safety Study/NHLBI Donor Repository. Transfusion. 1989;29:572-80. CrossrefMedlineGoogle Scholar
    • 8. . Update on acquired immune deficiency syndrome (AIDS)—United States. MMWR. 1982;31:507-14. MedlineGoogle Scholar
    • 9. Revision of the case definition of acquired immunodeficiency syndrome for national reporting—United States. Ann Intern Med. 1985; 103:402-3. LinkGoogle Scholar
    • 10. . Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR. 1987; 36:3S-15S. Google Scholar
    • 11. Edwards V and Mosley J. Reproducibility in quality control of protein (Western) immunoblot assay for antibodies to human immunodeficiency virus. Am J Clin Pathol. 1989;91:75-8. CrossrefMedlineGoogle Scholar
    • 12. Fletcher MBaron GAshman MFischl M, and Klimas N. Use of whole blood methods in assessment of immune parameters in immunodeficiency states. Diagn Clin Immunol. 1987;5:69-81. MedlineGoogle Scholar
    • 13. Parker JAdelsberg B, and Azen S. Leukocyte immunophenotyping of recipients of blood products. A multisite flow cytometry study: organization, standardization and quality control. Clin Immunol Immunopathol. 1990;55:187-220. CrossrefMedlineGoogle Scholar
    • 14. Howard FLedbetter JWong JBiber CStitson E, and Hertzenberg L. A human T lymphocyte differentiation marker defined by monoclonal antibodies that block Å-rosette formation. J Immunol. 1981;126:2117-22. CrossrefMedlineGoogle Scholar
    • 15. Fox DHussey R, and Fitzgerald K. Tal, a novel 105 KD human T cell activation antigen defined by a monoclonal antibody. J Immunol. 1984;133:1250-6. CrossrefMedlineGoogle Scholar
    • 16. Tsutomu TDi Maggio MLevine HSchlossman S, and Morimoto C. CD11 molecule defines two types of suppressor cells within the T8+ population. Cell Immunol. 1988;111:398-409. CrossrefMedlineGoogle Scholar
    • 17. Kung PGoldstein GReinherz E, and Schlossman S. Monoclonal antibodies defining distinctive human T cell surface antigens. Science. 1979;206:347-9. CrossrefMedlineGoogle Scholar
    • 18. Morimoto CLetvin N, and Boyd A. The isolation and characterization of the human helper inducer T cell subset. J Immunol. 1985;134:3762-9. CrossrefMedlineGoogle Scholar
    • 19. Morimoto CLetvin NDistaso JAldrich W, and Schlossman S. The isolation and characterization of the human suppressor inducer T cell subset. J Immunol. 1985;134:1508-15. CrossrefMedlineGoogle Scholar
    • 20. Reinherz EKung PGoldstein G, and Schlossman S. A monoclonal antibody reactive with the human cytotoxic/suppressor T cell subset previously defined by a heteroantiserum termed TH2. J Immunol. 1980;124:1301-7. CrossrefMedlineGoogle Scholar
    • 21. Horwitz DLinker-Israeli MGray J, and Lemaine C. Functional properties of CD8 positive lymphocyte subsets in systemic lupus erythematosus. J Rheumatol 1987;13(Suppl):49-52. Google Scholar
    • 22. Griffin JHercend TBeveridge R, and Schlossman S. Characterization of an antigen expressed by human natural killer cells. J Immunol. 1983;130:2947-51. CrossrefMedlineGoogle Scholar
    • 23. Abo T and Balch C. A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1). J Immunol. 1981;127:1024-9. CrossrefMedlineGoogle Scholar
    • 24. Stashenko PNadler LHardy R, and Schlossman S. Characterization of a human B lymphocyte specific antigen. J Immunol. 1980;125: 1678-85. CrossrefMedlineGoogle Scholar
    • 25. Abo T and Balch C. Characterization of HNK-1+ (Leu7) human lymphocytes. IL Distinguishing phenotypic and functional properties of natural killer cells from activated NK-like cells. J Immunol. 1982;129:1758-61. CrossrefMedlineGoogle Scholar
    • 26. Lawless J. Statistical Models and Methods for Lifetime Data. New York: Wiley; 1982. Google Scholar
    • 27. Hollander M and Wolfe D. Nonparametric Statistical Methods. New York: Wiley; 1973:114-9. Google Scholar
    • 28. Archer GBolten WCook LKendrick K, and Learment J. HIV infection in patients following blood transfusion [Abstract]. Program and Abstracts, Book 2, IV International Conference on AIDS. Stockholm: Swedish Ministry of Health and Social Affairs, World Health Organization; 1988:354. Google Scholar
    • 29. Berglund OBeckman S, and Grillner L. HIV transmission by blood transfusions in Stockholm 1979-1985: nearly uniform transmission from infected donors. AIDS. 1988;2:51-4. CrossrefMedlineGoogle Scholar
    • 30. Niland J. Association of donor characteristics with transmission of HIV infection to recipients [Abstract]. Abstracts Volume, III International Conference on AIDS. Washington, DC: U.S. Department of Health and Human Services, World Health Organization; 1987:24. Google Scholar
    • 31. . Natural history of primary infection with LAV in multitransfused patients. Blood. 1986; 68:89-94. CrossrefMedlineGoogle Scholar
    • 32. Donegan ELenes BTomasulo P, and Mosley J. Transmission of HIV-1 by component type and duration of shelf storage before transfusion. Transfusion. 1990:30:839-40. CrossrefGoogle Scholar
    • 33. Anderson KGorgone B, and Marlick R. Transfusion-acquired human immunodeficiency virus infection among immunocompromised persons. Ann Intern Med. 1986;105:519-27. LinkGoogle Scholar
    • 34. Peterman TJaffe H, and Feorino P. Transfusion-associated acquired immunodeficiency syndrome in the United States. JAMA. 1985;254:2913-7. CrossrefMedlineGoogle Scholar
    • 35. Giesecke JScalia-Tomba GBerglund OBerntorp ESchulman S, and Stigendal L. Incidence of symptoms and AIDS in 146 Swedish hemophiliacs and blood transfusion recipients infected with human immunodeficiency virus. Br Med J. 1988;297:99-102. CrossrefMedlineGoogle Scholar
    • 36. Eyster MGail M, and Ballard J. National history of human immunodeficiency virus infections in hemophiliacs; effect of T-cell subsets, platelet counts, and age. Ann Intern Med. 1987;107:1-6. LinkGoogle Scholar
    • 37. Mosley J. Effect of age on the expression of human immunodeficiency virus infection among hemophiliacs [Abstract]. Blood. 1987; 70:125 A. Google Scholar
    • 38. Goedert JKessler C, and Aledort L. A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia. N Engl J Med. 1989; 321:1141-8. CrossrefMedlineGoogle Scholar
    • 39. Jason JHilgartner M, and Holman R. Immune status of blood transfusion recipients. JAMA. 1985;253:1140-5. CrossrefMedlineGoogle Scholar
    • 40. Klimas NMorgan RSalvato F, and Fletcher M. Natural killer cells and T lymphocytes in chronic fatigue syndrome. Rev Infect Dis. 1989; [In press]. Google Scholar
    • 41. Schriemer PLongnecker D, and Mintz P. Possible immunosuppressive effects of perioperative blood transfusion in cancer patients. Anesthesiology. 1988;68:422-8. CrossrefMedlineGoogle Scholar
    • 42. Lennard TShenton B, and Borzotta A. The influence of surgical operations on components of the human immune system. Br J Surg. 1985;72:771-6. CrossrefMedlineGoogle Scholar
    • 43. Lynch F and Kirov S. Changes in blood lymphocyte populations following surgery. J Clin Lab Immunol. 1986;20:75-9. MedlineGoogle Scholar
    • 44. Fletcher MAzen S, and Adelsberg B. Immunophenotyping in a multicenter study: the Transfusion Safety Study experience. Clin Immunol Immunopathol. 1989;52:38-47. CrossrefMedlineGoogle Scholar

    This content is PDF only. To continue reading please click on the PDF icon.